Actualités

These stocks have terrific track records for dividend growth, and they're likely to continue raising their payouts for the foreseeable future.

Procter & Gamble (PG) has just updated investors with full year 2027 guidance, new quarterly earnings expectations, and fresh details on capital returns, including dividends and share buybacks, all released alongside its latest annual results. See our latest analysis for Procter & Gamble. At a share price of $146.44, Procter & Gamble has seen a 3.28% year to date share price return, while the 1 year total shareholder return is down 2.73%. This signals momentum that is still relatively muted...

Five Dividend Kings just posted blockbuster second-quarter results in a market that rewards almost nothing, and one of them happens to be Warren Buffett's favorite long-term hold. Defensive income investors take note: bargains this reliable rarely show up in a frothy summer market.

Procter & Gamble has one of the longest dividend increase streaks of any American company, but it's not inexpensive to wring $10,000 in year payouts from this stock.

There are stocks you own for growth. There are stocks you own for income. And then there are the rare ones where a business that appeared to be doing the slow, reliable work of a dividend compounder suddenly shows you something you were not expecting. Procter and Gamble has done exactly that with ...

This dividend royalty keeps proving that steady execution, smart innovation, and shareholder-friendly capital allocation are a winning long-term formula.

Procter & Gamble (NYSE:PG) is buying its way into wellness. On August 4, L Catterton announced it had signed a definitive agreement to sell Thorne, a science-backed health and wellness brand, to Procter & Gamble for $3.8 billion in cash. The deal lands a day after an August 3 analysis flagged a fiscal 2027 earnings […]

Procter & Gamble just logged its 70th consecutive dividend increase, yet Wall Street has turned skeptical, pointing to tariff costs, margin compression, and guidance at the lower end of its range. The cash flow statement is telling a completely different story.

Procter & Gamble (NYSE:PG) appointed Shailesh Jejurikar as Chairman of the Board, succeeding Jon R. Moeller following his retirement after 38 years at the company. The board transition shifts leadership at the top of Procter & Gamble’s governance structure as Moeller steps down from his role as Executive Chairman. Investors are watching the handover closely, given the potential long term implications for company culture, operations, and board oversight. For readers tracking long term...

A $425,000 nest egg can generate wildly different monthly paychecks depending on where you put it, but chasing the biggest number often destroys the very asset you need to last through your 70s.

Replicating a Social Security check with dividends sounds straightforward until you realize the yield you chase determines whether your income grows, stalls, or quietly disappears over the next two decades.

Consumer sentiment is flashing recession warnings, yet three blue-chip dividend legends are quietly building cases for returns that would shock most defensive investors heading into 2027.

Chasing a $50,000 monthly dividend stream sounds like a math problem, but the yield you pick determines whether your portfolio funds four decades of freedom or quietly cannibalizes itself while the checks keep arriving.

P&G navigates $1B cost headwind while guiding 1-3% organic sales growth for fiscal 2027.

A $1.25 million nest egg can fund a very different retirement depending on one number: your withdrawal yield. The gap between a conservative dividend portfolio and an aggressive one swings your annual income by tens of thousands of dollars, but the safer-looking choice does not always win.

Earnings season is showing that consumers are still spending and paying their bills, as indicated by SoFi and Visa.

NHTC, HCWC, and NAII sell into the growing nutrition and wellness space.

An 8% yield looks like a shortcut to $80,000 a year without selling a single share, but the brokerage account tells a different story than the headline number does.

Procter & Gamble stock rallies on $3.8 billion acquisition of Thorne. Here’s what the deal means for PG shares.

Wayfair CFO Kate Gulliver on signs of a rebound in the U.S.; Elon Musk outlined ambitious targets for SpaceX following its first-ever earnings report; Procter & Gamble will buy supplement company Thorne; plus, Portillo’s hires new CFO. Furniture and home improvement companies often offer good indicators for how the U.S. economy is performing, as those businesses reflect the sentiment of consumers and key discretionary spending behavior for items such as sofas, tables and decor.

Annuity payouts are the most competitive they have been in years, which makes the timing of this comparison unusually consequential for anyone sitting on a $675,000 nest egg and trying to decide which structure actually puts more money in their pocket for life.

Replacing a six-figure salary with dividends is a math problem first, and the capital requirement swings by more than a million dollars depending on one variable most investors treat as an afterthought.

The acquisition bolsters P&G's presence in the premium wellness space.

The deal, set to close later this year, would add Thorne to P&G's existing supplements portfolio that includes Metamucil, Align Probiotic, and New Chapter

Investing.com -- Procter & Gamble Co. reached an agreement to acquire supplement maker Thorne for $3.8 billion, with the deal set to be announced later today.

Thorne went public in late 2021 at a $525 million valuation but was taken private by asset manager L Catterton in 2023 in a $680 million transaction.

These relatively safe dividend stocks offer yields of more than 3%.

Procter & Gamble has underperformed the broader market over the past year, though analysts remain moderately optimistic on its future potential.

Consumer products behemoth Procter & Gamble (NYSE:PG) fell short of the market’s revenue expectations in Q2 CY2026 as sales only rose 1.5% year on year to $21.2 billion. Its non-GAAP profit of $1.43 per share was 1.6% above analysts’ consensus estimates.

The newly installed boss of Diageo has poached a senior Procter & Gamble (P&G) executive to join his leadership team, days before he unveils a revival plan for the maker of Guinness and Johnnie Walker. Sky News has learnt that Sujay Wasan, the head of P&G's oral care business in North America, is joining the FTSE-100 alcoholic drinks company as the head of its Asia-Pacific operations.